Zobrazeno 1 - 10
of 609
pro vyhledávání: '"Hultquist M"'
Autor:
Kalunian KC; Division of Rheumatology, Allergy and Immunology, University of California San Diego School of Medicine, La Jolla, California., Furie R; Division of Rheumatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York., Morand EF; School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia., Bruce IN; Centre for Epidemiology Versus Arthritis, The University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, and Manchester Academic Health Science Centre, Manchester, UK., Manzi S; Lupus Center of Excellence, Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania., Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Winthrop K; School of Public Health at Oregon Health and Science University, Portland, Oregon., Hupka I; Clinical Development, Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Warsaw, Poland., Zhang LJ; Global Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Werther S; Global Patient Safety, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Abreu G; Biometrics, Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hultquist M; Clinical Development, Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Tummala R; Clinical Development, Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Lindholm C; Clinical Development, Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Al-Mossawi H; Clinical Development, Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Publikováno v:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Feb; Vol. 75 (2), pp. 253-265. Date of Electronic Publication: 2022 Nov 11.
Autor:
Bruce IN; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal & Dermatological Sciences, The University of Manchester, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Furie RA; Division of Rheumatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA., Morand EF; Center for Inflammatory Disease, Monash University, Melbourne, Victoria, Australia., Manzi S; Department of Medicine, Lupus Center of Excellence, Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania, USA., Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Kalunian KC; Division of Rheumatology, Allergy, and Immunology, University of California San Diego, La Jolla, California, USA., Merrill JT; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Puzio P; BioPharmaceuticals R&D, AstraZeneca US, Gaithersburg, Maryland, USA., Maho E; BioPharmaceuticals R&D, AstraZeneca R&D, Cambridge, UK., Kleoudis C; BioPharmaceuticals R&D, AstraZeneca US, Durham, North Carolina, USA., Albulescu M; BioPharmaceuticals R&D, AstraZeneca R&D, Cambridge, UK., Hultquist M; BioPharmaceuticals R&D, AstraZeneca US, Gaithersburg, Maryland, USA., Tummala R; BioPharmaceuticals R&D, AstraZeneca US, Gaithersburg, Maryland, USA Raj.Tummala@astrazeneca.com.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2022 Jul; Vol. 81 (7), pp. 962-969. Date of Electronic Publication: 2022 May 17.
Autor:
Angier, Robert B., Boothe, James H., Hutchings, Brian L., Mowat, John H., Semb, Joseph, Stokstad, E. L. R., SubbaRow, Y., Waller, Coy W., Cosulich, Donna B., Fahrenbach, M. J., Hultquist, M. E., Kuh, Erwin, Northey, E. H., Seeger, Doris R., Sickels, J. P., Smith, James M.
Publikováno v:
Science, 1946 May . 103(2683), 667-669.
Externí odkaz:
https://www.jstor.org/stable/1673719
Autor:
Garai, Réka1,2 (AUTHOR) garai.reka@semmelweis.hu, Jánosi, Ágoston2,3 (AUTHOR), Krivácsy, Péter1,2 (AUTHOR), Herczeg, Vivien1 (AUTHOR), Kói, Tamás2,4 (AUTHOR), Nagy, Rita2,3,5 (AUTHOR), Imrei, Marcell2,3 (AUTHOR), Párniczky, Andrea2,3,5 (AUTHOR), Garami, Miklós2,6 (AUTHOR), Hegyi, Péter2,5,7 (AUTHOR), Szabó, Attila József1,2,6,8 (AUTHOR)
Publikováno v:
Journal of Translational Medicine. 10/4/2024, Vol. 22 Issue 1, p1-15. 15p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carbonell Estrany X, Simões EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA, Motavizumab Study Group [, FALDELLA, GIACOMO, LANARI, MARCELLO
OBJECTIVE: Palivizumab reduces respiratory syncytial virus (RSV) hospitalization in children at high risk by ∼50% compared with placebo. We compared the efficacy and safety of motavizumab, an investigational monoclonal antibody with enhanced anti-R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e6b83d35962e137e7509c20158f967d
http://hdl.handle.net/11585/92930
http://hdl.handle.net/11585/92930
Autor:
Wang, Yang1 (AUTHOR), Liu, Li1 (AUTHOR) lli01@jlu.edu.cn
Publikováno v:
BMC Immunology. 7/26/2024, Vol. 25 Issue 1, p1-10. 10p.
Autor:
Angier, Robert B., Boothe, James H., Hutchings, Brian L., Mowat, John H., Semb, Joseph, Stokstad, E. L. R., SubbaRow, Y., Waller, Coy W., Cosulich, Donna B., Fahrenbach, M. J., Hultquist, M. E., Kuh, Erwin, Northey, E. H., Seeger, Doris R., Sickels, J. P., Smith, James M.
Publikováno v:
Science, 1945 Aug . 102(2644), 227-228.
Externí odkaz:
https://www.jstor.org/stable/1672497
Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus.
Autor:
Greth W; MedImmune, Gaithersburg, MD, USA., Robbie GJ; MedImmune, Gaithersburg, MD, USA., Brohawn P; MedImmune, Gaithersburg, MD, USA., Hultquist M; MedImmune, Gaithersburg, MD, USA., Yao B; MedImmune, Gaithersburg, MD, USA.
Publikováno v:
Immunotherapy [Immunotherapy] 2017 Jan; Vol. 9 (1), pp. 57-70.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.